I was just informed by my rheumatologist's office that Evusheld was approved for emergency use ONCE ONLY. Hopefully this will be extended by the government since the treatment is good for 6 months. As with everything COVID-19, policies are fluid, but if the past is predictive, CDC gives immunocompromised patients lowest priority if that. The other question of course is how effective Evusheld is against variants BA.4 and BA.5 which will dominate the next wave.